BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Interleukin-17 (IL-17) receptor B (IL17RB)

April 2, 2015 7:00 AM UTC

Studies in patient samples and mice suggest inhibiting IL17RB could help treat pancreatic ductal adenocarcinoma (PDAC). In PDAC samples from patients, IL17RB levels were associated with post-operative...